GoKawiilLong-acting drug engineering aims to replace daily pills with rare doses
Researchers are redesigning drug molecules and delivery systems so a single injection or implant can maintain therapeutic effects for weeks, months, or even years instead of requiring daily dosing. Techniques include chemical modifications that slow drug breakdown, polymer depots, and implantable devices that release medication gradually over extended periods.
GoKawiil's interpretation of the reporting above, not reported fact.
Long-acting formulations could dramatically improve treatment adherence for chronic conditions like HIV, diabetes, and psychiatric disorders, where missed doses often undermine outcomes. This shift also opens new business models for pharmaceutical companies, as reformulated long-acting versions of existing drugs can extend patent life and create fresh revenue streams.
- Scientists are engineering drugs to remain active in the body for extended periods, reducing dosing frequency.
- Methods include chemical modification, polymer-based depots, and implantable slow-release devices.
- This approach could boost medication adherence and offers pharma companies a way to extend the commercial life of existing drugs.
Source: nature.com — Deighton, 2026-09-09
Published there as: “Dose once, treat forever: drugs are being engineered to last much longer”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.